RB1 and acute lymphoblastic leukemia: Based on the targets of ON108110 and the increased sensitivity of MCL and T-ALL cell lines to the anti-proliferative effects of this compound, we next examined the mRNA and protein levels of CK2 subunits and the phosphorylation status of target pRB in a panel of MCL and T-ALL cell lines.